Topic

Precision Oncology

Fillmore has focused on the integration of large-scale genomic, clinical, and imaging data to refine cancer stratification and treatment selection. His work includes the development of national data repositories and the application of machine learning to predict survival outcomes in lung cancer and identify targetable molecular subgroups in advanced prostate cancer. Additionally, he has investigated the impact of age on immunotherapy biomarkers, providing evidence that older patients may maintain a robust capacity for response to immune checkpoint blockade.

Publications (5)

2023
2021
2019
2019